{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:49:16Z","timestamp":1764078556557},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T00:00:00Z","timestamp":1153094400000},"content-version":"vor","delay-in-days":4735,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1993,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tumour\u2010associated HMFG2 monoclonal antibody (MAb) was labelled with indium\u2010111 and administered intravesically to 20 patients with known or suspected superficial bladder carcinoma. The antibody solution was kept in the bladder for 1 hr and was then washed out. Cystoscopy was performed at 2 and 24 hr after instillation. Radioactivity of tumour and normal tissue obtained from the bladder during cystoscopy and cells recovered from urine after the instillation were counted in a gamma\u2010counter. Conventional histology, immunocytochemistry and autoradiography were also performed. Mean uptake at 2 and at 24 hr was higher in tumours than in normal samples. Autoradiography showed selective accumulation of radioactivity in cells which expressed the antigen detected by the HMFG2 MAb. There was no correlation of tumour uptake with the grade of tumour. No radioactivity was found in the blood of patients after the instillation. Based on dosimetric calculations, however, the radiation dose that can be delivered to the tumours is not sufficient to be cytotoxic, possibly due to inadequate penetration and retention by tumour tissue. Nevertheless, the significant difference between antibody uptake by the tumours and that by normal urothelium, observed in our study, allow for the possibility of using this approach therapeutically.<\/jats:p>","DOI":"10.1002\/ijc.2910540604","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T23:52:02Z","timestamp":1171929122000},"page":"899-903","source":"Crossref","is-referenced-by-count":16,"title":["Intravesical administration of indium\u2010111\u2010labelled hmfg2 monoclonal antibody in superficial bladder carcinomas"],"prefix":"10.1002","volume":"54","author":[{"given":"A.","family":"Bamias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Epenetos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910280105"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.293"},{"key":"e_1_2_1_4_1","first-page":"724","article-title":"Intravesical administration of radiolabelled anti\u2010tumour monoclonal antibody in bladder carcinoma","volume":"51","author":"Bamias A.","year":"1991","journal-title":"Cancer Res."},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4049\/jimmunol.131.1.508","article-title":"Complexity of expression of antigenic determinants, recognised by monoclonal antibodies HMFG1 and HMFG2 in normal and malignant human mammary epithelial cells","volume":"131","author":"Burchell J.","year":"1983","journal-title":"J. Immunol."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.11.1191"},{"key":"e_1_2_1_7_1","first-page":"3131","article-title":"Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies","volume":"52","author":"de Harven E.","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(87)90042-9"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.12.1890"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92495-X"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(83)90311-3"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840301)53:5<1025::AID-CNCR2820530502>3.0.CO;2-D"},{"key":"e_1_2_1_13_1","first-page":"1636","article-title":"Antibody\u2010guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal\u2010growth\u2010factor receptor and placental alkaline phosphatase","volume":"30","author":"Kalofonos H. P.","year":"1989","journal-title":"J. nucl. Med."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.199"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(79)90139-7"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55018-1"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880301)61:5<857::AID-CNCR2820610502>3.0.CO;2-S"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1985.tb08980.x"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.112"},{"key":"e_1_2_1_20_1","first-page":"115","article-title":"Properties of monoclonal antibodies to mouse Ig allotypes and Ia antigens","volume":"81","author":"Oi V. T.","year":"1979","journal-title":"Curr. Topics Microbiol. Immunol."},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450632"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1986.125"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910410726"},{"key":"e_1_2_1_24_1","first-page":"5","volume-title":"Medical internal radiation dose (MIRD(","author":"Snyder W. S.","year":"1978"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910280104"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910540604","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910540604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:28:50Z","timestamp":1698229730000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910540604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7,30]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1993,7,30]]}},"alternative-id":["10.1002\/ijc.2910540604"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910540604","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7,30]]}}}